Lana Caldwell

Statistics

Publications

Citations

H-Index

Active since

2017

Affiliations

Translational Genomics Research Institute(Current)

HonorHealth

Mayo Clinic in Arizona

Lana Caldwell is an author at Translational Genomics Research Institute specializing in oncology, pancreatic cancer, and pancreatic cancer pharmacotherapy.

Publications per year

2017–2019

Publications

A phase II pilot trial of nivolumab (N) + albumin bound paclitaxel (AP) + paricalcitol (P) + cisplatin (C) + gemcitabine (G) (NAPPCG) in patients with previously untreated metastatic pancreatic ductal adenocarcinoma (PDAC).

Erkut Borazanci, Gayle Jameson, Mitesh J. Borad et al. · Journal of Clinical Oncology · 2018 · 21 citations

Medicine, Oncology, Pharmacology +17

A phase II pilot trial of nivolumab + albumin bound paclitaxel + paricalcitol + cisplatin + gemcitabine (NAPPCG) in patients (pts) with previously untreated metastatic pancreatic ductal adenocarcinoma.

Erkut Borazanci, Gayle Jameson, Mitesh J. Borad et al. · Journal of Clinical Oncology · 2017 · 16 citations

Medicine, Oncology, Pharmacology +17

An Analysis of Patients with DNA Repair Pathway Mutations Treated with a PARP Inhibitor

Erkut Borazanci, Ronald L. Korn, Winnie S. Liang et al. · The Oncologist · 2019 · 14 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

1–3 of 3